Fig. 6: Response to chemotherapy according to the SLA. | Blood Cancer Journal

Fig. 6: Response to chemotherapy according to the SLA.

From: Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia

Fig. 6

A In vitro testing of cytarabine (AraC) activity in 47 AML samples. B Early chemosensitivity according to SLA was evaluated in patients by measuring the percentage of residual blasts in bone marrow at day 15 of induction chemotherapy (n = 475). C Prognostic impact of SLA on overall survival for patients from TUH cohort treated with intensive chemotherapy (n = 1266). See Table S2 for multivariate analysis results. D Prognostic impact of SLA on overall survival for younger patients (<60 years) from TUH cohort treated with intensive chemotherapy (n = 638).

Back to article page